The Recall Desk
ModerateFDA (Devices)·Z-0522-2016·Announced 2015-12-30

Ameditech ProScreen 12 Panel Dip Card Recalled for Reduced Benzodiazepine Reactivity

Ameditech is recalling ProScreen 12 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences, and the issue is a specific reactivity defect rather than a direct physical hazard.

Plain-English summary

Ameditech Inc is recalling 60 kits of ProScreen 12 Panel Dip Cards, Item No. PSD-12BUP. The affected products were distributed nationwide.

The recall was initiated because the drugs of abuse tests have shown reduced reactivity for up to two of the nineteen Benzodiazepine (BZO) compounds listed in the product insert. The specific compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Consumers and healthcare providers should stop using the affected products and contact Ameditech Inc for further instructions.

The recalled product

Product
ProScreen 12 Panel Dip Card, Item No. PSD-12BUP
Manufacturer
Ameditech Inc
Affected units
60

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • 152401

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 59 recalled by Ameditech Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 59 products in this recall →